https://investingnews.com/news/biotech-investing/u.s.food-and-drug-administration-approves-bristol-myers-squibbs-breyanzi-a-new-car-t-cell-therapy-for-adults-with-relapsed-or-refractory-large-b-cell-lymphoma/
U.S. Food and Drug Administration Approves Bristol Myers Squibb's Breyanzi , a New CAR T Cell...
Mar 19, 2024 - Breyanzi demonstrated a 73% overall response rate and 54% complete response (CR) rate in the largest pivotal trial in 3L+ LBCL, TRANSCEND NHL 001 trial...
https://www.usda.gov/about-usda/news/press-releases/2019/03/07/usda-and-fda-announce-formal-agreement-regulate-cell-cultured-food-products-cell-lines-livestock-and
USDA and FDA Announce a Formal Agreement to Regulate Cell-Cultured Food Products from Cell Lines of...